Welcome to our dedicated page for Huntington Bancshares SEC filings (Ticker: HBAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Huntington Bancshares Incorporated filings document the regulatory record of a regional bank holding company with Nasdaq-listed common stock and preferred depositary shares. The company's Form 8-K filings record dividend declarations on common and preferred stock, Regulation FD presentations, shareholder-vote results, and other material-event disclosures.
Definitive proxy statements cover annual meeting proposals, director elections, executive compensation, shareholder voting matters, and governance practices. Filing disclosures also identify Huntington's capital structure, including common stock and depositary shares representing interests in non-cumulative perpetual preferred stock, along with operating and financial results, risk factors, and other bank holding company reporting subjects.
Huntington Bancshares Incorporated announced its earnings release for the quarter ended September 30, 2025 and made a Quarterly Financial Supplement available. Management will host an earnings conference call on October 17, 2025 at 9:00 a.m. Eastern.
The earnings news release (Exhibit 99.1) and the Quarterly Financial Supplement (Exhibit 99.2) are furnished and available via the Investor Relations section of Huntington’s website. The filing also includes forward‑looking statements language referencing a proposed transaction with Veritex and related risk factors.
Huntington Bancshares Incorporated reports that it has received regulatory approval from both the Federal Reserve and the Office of the Comptroller of the Currency for its previously announced merger with Veritex Holdings, Inc. Veritex will merge into Huntington, and Veritex Community Bank will merge into The Huntington National Bank, with Huntington and its bank remaining the surviving entities.
All required regulatory approvals for the mergers have now been obtained. The companies expect to close the mergers on October 20, 2025, subject to remaining customary closing conditions in their merger agreement. Veritex shareholders approved the transaction at a special meeting held on September 22, 2025.
Donnell R. White, listed as Chief DEI Officer, SVP, filed a Form 4 reporting changes in beneficial ownership of HUNTINGTON BANCSHARES INC (HBAN). The filing discloses two non-derivative transactions on 10/01/2025: acquisition of 156.853 shares (reported with a post-transaction holding of 23,979.49 shares, direct) and acquisition of 9.906 shares (reported post-transaction indirect holding of 1,118.647 shares through the issuer's 401(k) Plan). Both transactions list a price of $0.0000. The filing includes an Exhibit 24 power of attorney and is signed by an attorney-in-fact on 10/03/2025. The document states the filing should not be construed as admission of beneficial ownership.
Zachary Jacob Wasserman, identified as CFO and Senior Exec. V.P. of HUNTINGTON BANCSHARES INC (HBAN), reported an acquisition on 10/01/2025 of 2,434.987 shares of common stock with a reported price of $0.0000 (indicative of a grant or non‑cash issuance). After the transaction he beneficially owns 282,176.164 shares. The Form 4 was signed by an attorney‑in‑fact on 10/03/2025.
Jeffrey L. Tate, a director of Huntington Bancshares Inc. (HBAN), reported acquisitions on 10/01/2025 under a director deferred compensation arrangement. The filing shows 461.241 shares of common stock acquired at a stated price of $0.0000, increasing his direct holdings to 112,657.268 shares. An additional 45.238 shares were recorded as indirect holdings, bringing that total to 5,063.708 shares. The Form 4 includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact on 10/03/2025.
Stephen D. Steinour, who is listed as President, CEO & Chairman and a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 disclosing non-derivative stock transactions dated 10/01/2025. The filing reports two acquisitions of common stock on that date: 6,326.503 shares and 491.145 shares, each recorded with a price of $0.0000. Following the reported transactions the document lists a total direct beneficial holding of 1,872,763.404 shares and various indirect holdings allocated to plans and trusts, including 3,441,119.559, 2,898,505, 496,500, 90,363.268, and other smaller allocations as shown in the filing. The Form 4 includes an exhibit index reference to a substitute power of attorney and is signed by an attorney-in-fact on 10/03/2025.
Brantley J. Standridge, identified as Senior Exec. V.P. of Huntington Bancshares Inc. (HBAN), reported an acquisition of 2,376.67 shares of Common Stock on 10/01/2025 via a Form 4. The reported transaction lists a price of $0.0000 and shows 331,168.429 shares beneficially owned following the transaction. The filing includes an Exhibit 24 substitute power of attorney and was signed on behalf of the reporting person by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025.
Roger J. Sit, a director of HUNTINGTON BANCSHARES INC /MD/ (HBAN), reported purchases on 10/01/2025. The Form 4 shows a direct acquisition of 1,514.358 shares (transaction code A) at a reported price of $0.0000, leaving 193,110.333 shares held directly after the transaction. The filing also reports an indirect acquisition of 357.324 shares, bringing indirect holdings to 39,997.025 shares via several vehicles: 22,921 shares in the Director Deferred Compensation Plan, 152,572 shares by the Richard A. Sit Trust, 4,713 shares by a trust, and 152,572 noted for Sit Investment Associates.
The filing includes an exhibit: Exhibit 24 (Substitute Power of Attorney), and is signed by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025. The filer clarifies the statement is not an admission of beneficial ownership for Section 16 purposes.
Huntington Bancshares (HBAN) director Teresa H. Shea reported acquisitions on a Form 4 dated 10/01/2025. The filing shows an acquisition of 182.758 shares of Common Stock directly and 50.96 shares indirectly under the Director Deferred Compensation Plan, for a combined 233.718 shares. The reported price for both entries is $0.0000, and the holdings after the transactions are 21,274.515 shares held directly and 5,704.219 shares held indirectly. The filer is identified as a Director, and the Form was filed by one reporting person.
Katherine M. A. Kline, a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 reporting transactions dated 10/01/2025. The filing reports the acquisition of 800.06 shares of common stock and an additional acquisition of 44.026 shares attributable to a director deferred compensation plan, both shown at a price of $0.0000. After the reported transactions, the filing lists 88,755.371 shares as directly beneficially owned and 4,927.986 shares as indirectly beneficially owned via the deferred compensation plan.
The Form 4 identifies the reporting persons address as Huntington Center, 41 S. High Street, Columbus, OH 43215 and includes an exhibit index reference to a substitute power of attorney. The filing contains the signature of an attorney-in-fact dated 10/03/2025. The statement clarifies that the filing is not an admission of beneficial ownership for Section 16 purposes.